Our partners
We believe that to achieve our mission and eliminate hepatitis by 2030 then we need to work with a diverse range of stakeholders.
Our partners help us achieve our mutual goals and benefit the lives of the people and communities impacted by hepatitis.
Official Relations
Our official relations status with the World Health Organization and our consultative status with United Nations ECOSOC enable us to have a seat at the table and effect policy change at a global level.
Additionally WHA is represented on global advisory groups on treatment guidelines and on groups working towards Universal Health Coverage (UHC).
Strategic partners
American Association for the Study of Liver Diseases (AASLD)
Asian Pacific Association for the Study of the Liver (APASL)
CDA Foundation
Centers for Disease Control and Prevention (CDC)
Clinton Health Assess Initiative (CHAI)
Coalition Plus
Coalition to Eradicate Viral Hepatitis in Asia-Pacific (CEVHAP)
European Association for the Study of the Liver (EASL)
European Liver Patients Association (ELPA)
Foundation for Innovative Diagnostics (FIND)
IAPAC
Médecins du Monde (MDM)
Médecins Sans Frontières (MSF)
Medicines Patent Pool (MPP)
Union for International Cancer Control (UICC)
UNITAID
World Health Organization (WHO)
